CHGX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ChitogenX, Inc. is a clinical stage biotech company, which engages in the development of therapeutic soft tissue repair technologies for orthopaedic and sports medicine surgeries. Its products include Ortho-R, Ortho-M, and Ortho-C. The company was founded on February 5, 2015 and is headquartered in Kirkland, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
CHGX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company